1123 Merck OncoImmune
BioCentury & Getty Images

Deals

OncoImmune's choice to repurpose GvHD program for COVID pays off via $425M takeout by Merck

Nov 24, 2020 | 1:22 AM GMT

OncoImmune’s

Read the full 288 word article

How to gain access

Continue reading with a
two-week free trial.